Bio-Works Technologies AB (BIOWKS) - Total Liabilities

Latest as of September 2025: Skr22.52 Million SEK ≈ $2.42 Million USD

Based on the latest financial reports, Bio-Works Technologies AB (BIOWKS) has total liabilities worth Skr22.52 Million SEK (≈ $2.42 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Bio-Works Technologies AB (BIOWKS) cash flow conversion to assess how effectively this company generates cash.

Bio-Works Technologies AB - Total Liabilities Trend (2015–2024)

This chart illustrates how Bio-Works Technologies AB's total liabilities have evolved over time, based on quarterly financial data. See Bio-Works Technologies AB (BIOWKS) shareholders funds for net asset value and shareholders' equity analysis.

Bio-Works Technologies AB Competitors by Total Liabilities

The table below lists competitors of Bio-Works Technologies AB ranked by their total liabilities.

Company	Country	Total Liabilities
Naos Small Cap Opportunities Company Ltd AU:NSC	Australia	AU$13.28 Million
Mohenz.Co.Ltd KQ:006920	Korea	₩19.16 Billion
Jentayu Sustainables Bhd KLSE:5673	Malaysia	RM63.70 Million
SHL Telemedicine Ltd American Depositary Shares NASDAQ:SHLT	USA	$41.51 Million
Wellbiotec Co. Ltd. KO:010600	Korea	₩11.76 Billion
Camino Minerals Corporation V:COR	Canada	CA$4.13 Million
TransAct Technologies Incorporated NASDAQ:TACT	USA	$13.21 Million
Wintec Co. Ltd KQ:320000	Korea	₩14.21 Billion

Liability Composition Analysis (2015–2024)

This chart breaks down Bio-Works Technologies AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Bio-Works Technologies AB market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.26	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.75	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.43	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Bio-Works Technologies AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Bio-Works Technologies AB (2015–2024)

The table below shows the annual total liabilities of Bio-Works Technologies AB from 2015 to 2024.

Year	Total Liabilities	Change
2024-12-31	Skr7.91 Million ≈ $851.57K	-56.33%
2023-12-31	Skr18.12 Million ≈ $1.95 Million	-24.25%
2022-12-31	Skr23.92 Million ≈ $2.57 Million	+93.65%
2021-12-31	Skr12.35 Million ≈ $1.33 Million	+53.57%
2020-12-31	Skr8.04 Million ≈ $865.66K	+36.48%
2019-12-31	Skr5.89 Million ≈ $634.29K	+2.26%
2018-12-31	Skr5.76 Million ≈ $620.30K	-3.76%
2017-12-31	Skr5.99 Million ≈ $644.51K	+35.01%
2016-12-31	Skr4.44 Million ≈ $477.38K	+92.79%
2015-12-31	Skr2.30 Million ≈ $247.62K	--

About Bio-Works Technologies AB

ST:BIOWKS Sweden Biotechnology

Market Cap

$33.60 Million

Skr312.19 Million SEK

Market Cap Rank

#23341 Global

#448 in Sweden

Share Price

Skr3.14

Change (1 day)

+1.29%

52-Week Range

Skr1.26 - Skr3.80

All Time High

Skr28.60